サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1427764

結膜炎治療薬の世界市場レポート 2024年

Conjunctivitis Treatment Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
結膜炎治療薬の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

結膜炎治療薬の市場規模は、今後数年間で着実に成長すると予想されています。 2028年には4.0%の年間複合成長率（CAGR）で54億8,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、いくつかの重要な要因に起因すると考えられます。これらには、結膜炎の発生を最小限に抑えることを目的とした予防ヘルスケア対策の重視の高まり、結膜炎の世界の発生率の増加による治療需要の増加、ヘルスケア意識の高まりと医療サービスへのアクセスの改善、結膜炎の一因となる環境アレルゲンの増加が含まれます。結膜炎の有病率が高く、高齢化人口が拡大しているため、目に関連した問題が起こりやすくなっています。この期間に予想される主な動向には、治療の承認と基準に影響を与える規制の変更、患者の快適性の向上と症状の効果的な管理への重点の集中、結膜炎の診断と管理における人工知能の統合、包括的なソリューションを提供する併用療法の需要の高まりなどが含まれます。そして、結膜炎治療薬に対するハーブ療法や代替療法への関心が高まっています。

結膜炎治療薬市場は、結膜炎の有病率の増加により成長する準備ができています。結膜の炎症である結膜炎は症例数が増加しており、効果的な治療選択肢の需要が高まっています。結膜炎の医師の診察や治療を求めることはより一般的になり、結膜炎治療薬市場の成長に貢献しています。 2022年 6月の時点で、米国医師会の統計によると、成人では細菌性結膜炎と比較してウイルス性結膜炎の有病率が高く、それぞれ78%と16%を占めています。小児では細菌性結膜炎が71％とより多く、ウイルス性結膜炎が16％を占めました。この結膜炎症例の増加傾向は、治療選択肢の必要性を強調し、それによって結膜炎治療薬市場を強化します。

結膜炎治療薬市場の成長は、高齢者人口の増加によってさらに加速されます。高齢者集団を構成する高齢者は、結膜炎を含むさまざまな目の病気にかかりやすくなります。免疫力の低下、既存の病状、加齢に伴う目の健康状態の変化などの要因が、高齢者の感染症に対する脆弱性を高めています。世界貿易機関の2022年 10月のデータによると、世界の60歳以上の人口は2021年には10億人から14億人に増加しました。将来の予測では、世界の60歳以上の成人人口は2050年までに2倍となり、21億人に達すると予想されています。十億。さらに、80歳以上の人口は2020年から2050年の間に3倍となり、4億2,600万人に達すると予想されています。この高齢化への人口動態の変化は、高齢者の特有のニーズに合わせた治療に対する需要の増加を反映し、結膜炎治療薬市場の重要な推進力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の結膜炎治療市場の促進要因と制約要因
    • 市場の促進要因
    • 市場の抑制要因
  • 世界の結膜炎治療市場規模実績と成長、2018年～2023年
  • 世界の結膜炎治療市場規模と成長予測、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の結膜炎治療市場、薬剤クラス別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 抗生物質
  • 抗ウィルス薬
  • 抗アレルギー剤
  • 人工涙液
  • 世界の結膜炎治療市場、疾患タイプ別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • アレルギー性結膜炎
  • 細菌性結膜炎
  • ウイルス性結膜炎
  • 世界の結膜炎治療市場、投与経路別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 経口
  • 局所
  • 世界の結膜炎治療市場、エンドユーザー別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 病院
  • ホームケア
  • 専門クリニック
  • その他のエンドユーザー

第7章 地域および国の分析

  • 世界の結膜炎治療市場、地域別、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 世界の結膜炎治療市場、国別、実績および予測、2018年～2023年、2023年～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 結膜炎治療市場の競合情勢
  • 結膜炎治療市場の企業プロファイル
    • Pfizer Inc.
    • Johnson and Johnson
    • AbbVie Inc.
    • Novartis AG
    • Sanofi SA

第31章 その他の主要・革新的企業

  • Boehringer Ingelheim
  • Viatris Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Alcon Laboratories Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Aurobindo Pharma Limited
  • Dr. Reddy's Laboratories Ltd.
  • Cipla Inc.
  • Bausch Health Companies Inc
  • Santen Pharmaceuticals Co. Ltd
  • Lupin Limited
  • Allergan PLC
  • Alembic Pharmaceuticals Ltd
  • Akorn Inc.
  • Micro Labs Ltd.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r13608

Conjunctivitis treatment encompasses medical interventions and therapies aimed at addressing the symptoms and root causes of conjunctivitis, commonly known as pink eye. These treatments involve the use of diverse medications to alleviate inflammation, manage symptoms, and prevent the spread of the infection.

The primary categories of drugs utilized for conjunctivitis treatment include antibiotics, antivirals, anti-allergic medications, and artificial tears. Antibiotics, specifically targeting bacterial infections, function by either eliminating bacteria or hindering their growth. They are frequently prescribed for conjunctivitis caused by bacterial agents to mitigate inflammation and eradicate the bacterial infection. These medications are applied orally or topically and are instrumental in addressing various conditions such as allergic conjunctivitis, bacterial conjunctivitis, and viral conjunctivitis. The usage of these medications spans across various end-users, including hospitals, homecare settings, specialty clinics, and other healthcare facilities.

The conjunctivitis treatment research report is one of a series of new reports from The Business Research Company that provides conjunctivitis treatment market statistics, including the conjunctivitis treatment industry's global market size, regional shares, competitors with a conjunctivitis treatment market share, detailed conjunctivitis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the conjunctivitis treatment industry. This conjunctivitis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The conjunctivitis treatment market size has grown steadily in recent years. It will grow from $4.49 billion in 2023 to $4.7 billion in 2024 at a compound annual growth rate (CAGR) of 4.6%. The growth observed in the historical period can be attributed to several factors. These include the globalization of eye care services, which expanded their reach and accessibility across different regions, increased affordability and availability of treatments, a growing demand for combination therapies that offer comprehensive solutions, innovations in anti-inflammatory treatments providing improved care options, and advancements in eye care infrastructure contributing to enhanced services and accessibility for patients.

The conjunctivitis treatment market size is expected to see steady growth in the next few years. It will grow to $5.48 billion in 2028 at a compound annual growth rate (CAGR) of 4.0%. The anticipated growth in the forecast period can be attributed to several key factors. These include an increased emphasis on preventive healthcare measures aimed at minimizing the occurrence of conjunctivitis, a rising global incidence of this condition leading to higher demand for treatment, the growth of healthcare awareness and improved access to medical services, an increase in environmental allergens contributing to a higher prevalence of conjunctivitis, and the expanding aging population more susceptible to eye-related issues. Major trends expected in this period encompass regulatory shifts affecting treatment approvals and standards, a heightened focus on enhancing patient comfort and managing symptoms effectively, the integration of artificial intelligence in the diagnosis and management of conjunctivitis, a growing demand for combination therapies providing comprehensive solutions, and an increased interest in herbal and alternative remedies for conjunctivitis treatment.

The conjunctivitis treatment market is poised for growth, fueled by the rising prevalence of conjunctivitis cases. Conjunctivitis, the inflammation of the conjunctiva, has witnessed an increase in instances, driving the demand for effective treatment options. Seeking medical attention and treatment for conjunctivitis has become more common, contributing to the growing conjunctivitis treatment market. As of June 2022, statistics from the American Medical Association indicated a higher prevalence of viral conjunctivitis compared to bacterial conjunctivitis among adults, accounting for 78% and 16%, respectively. In children, bacterial conjunctivitis was more prevalent at 71%, while viral conjunctivitis accounted for 16%. This upward trend in conjunctivitis cases emphasizes the need for treatment options, thereby bolstering the conjunctivitis treatment market.

The growth of the conjunctivitis treatment market is further augmented by an increasing geriatric population. The elderly, constituting the geriatric population, are more susceptible to various eye conditions, including conjunctivitis. Factors such as weakened immune systems, pre-existing medical conditions, and age-related changes in eye health contribute to the heightened vulnerability of the elderly to infections. According to October 2022 data from the World Trade Organization, the global population aged 60 and above increased from 1 billion to 1.4 billion in 2021. Projections for the future indicate a doubling of the world's population of adults aged 60 and above by 2050, reaching 2.1 billion. Additionally, the number of individuals aged 80 or more is anticipated to triple between 2020 and 2050, reaching 426 million. This demographic shift toward an aging population is a significant driver for the conjunctivitis treatment market, reflecting an increased demand for treatments tailored to the specific needs of the elderly.

Product innovation stands out as a pivotal trend gaining momentum in the conjunctivitis treatment market. Leading companies within this market are strategically focusing on the development of innovative products to reinforce their market presence. A noteworthy example is Johnson & Johnson Vision Care, a US-based division specializing in eye health and vision care. In March 2022, the company secured approval from the US FDA for ACUVUE Theravision with Ketotifen, a groundbreaking drug-eluting contact lens. This novel technology integrates ACUVUE daily disposable contact lenses with a well-established antihistamine, creating an entirely new category in the market. ACUVUE Theravision with Ketotifen is specifically designed to prevent ocular itch caused by allergic conjunctivitis while offering vision correction for eligible contact lens wearers without red eyes and with up to 1.00 D of astigmatism.

Major players in the conjunctivitis treatment market are also directing their efforts toward product development and launches, particularly in the realm of ophthalmic products. This category encompasses medical and pharmaceutical products tailored for the care and treatment of the eyes and vision-related conditions. A notable illustration comes from Harrow, Inc., a US-based company specializing in ophthalmic healthcare. In July 2023, Harrow, Inc. unveiled five innovative ophthalmic products in the United States, showcasing a diverse range of solutions for various eye conditions. Notable among these products are FLAREX (fluorometholone acetate ophthalmic suspension) 0.1%, targeting steroid-responsive inflammatory eye conditions, and NATACYN (natamycin ophthalmic suspension) 5%, the only FDA-approved topical ophthalmic antifungal medication addressing fungal blepharitis, conjunctivitis, and keratitis. TOBRADEX ST (tobramycin/dexamethasone ophthalmic suspension) 0.3%/0.05% offers a solution for inflammatory ocular conditions requiring a corticosteroid with a risk of bacterial ocular infection. VERKAZIA (cyclosporine ophthalmic emulsion) 0.1%, designated as an orphan product, serves the treatment of vernal keratoconjunctivitis in both children and adults. Lastly, ZERVIATE (cetirizine ophthalmic solution) 0.24% addresses ocular itching associated with allergic conjunctivitis. This strategic product launch highlights Harrow, Inc.'s commitment to providing diverse and targeted solutions for a spectrum of ophthalmic conditions.

In March 2022, Thea Pharma Inc., a U.S.-based pharmaceutical company specializing in eye care products, successfully acquired seven branded ophthalmic products from Akorn Operating Company LLC. The specific financial details of this transaction were not publicly disclosed. This strategic acquisition represents a significant move by Thea Pharma Inc. to reinforce its presence as a key provider of specialized eye care products tailored to meet the needs of eye care professionals across the United States. Akorn Operating Company LLC, the seller, is a pharmaceutical firm based in the U.S. and focuses on manufacturing ophthalmic solutions, injectables, and oral liquid pharmaceuticals.

Major companies operating in the conjunctivitis treatment market report are Pfizer Inc., Johnson and Johnson, AbbVie Inc., Novartis AG, Sanofi SA, Boehringer Ingelheim, Viatris Inc., Teva Pharmaceutical Industries Ltd., Alcon Laboratories Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Cipla Inc., Bausch Health Companies Inc, Santen Pharmaceuticals Co. Ltd, Lupin Limited, Allergan PLC, Alembic Pharmaceuticals Ltd, Akorn Inc., Micro Labs Ltd., Indoco Remedies Ltd., Mankind Pharma Ltd., AFT pharmaceuticals Limited, Ocular Therapeutics Inc., Sirion Therapeutics Inc., Jabs Biotech Pvt. Ltd., Atopix Therapeutics Ltd., JAWA Pharmaceuticals Pvt. Ltd., Eyevance Pharmaceuticals LLC, NicOx SA

North America was the largest region in the conjunctivitis treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the conjunctivitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the conjunctivitis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The conjunctivitis treatment market consists of revenues earned by entities by providing antibiotic therapy and eye-warming therapy services. The market value includes the value of related goods sold by the service provider or included within the service offering. The conjunctivitis treatment market also includes sales of eye drops, ointments, ophthalmic steroids, non-steroidal anti-inflammatory drugs, and antihistamines, which are used in conjunctivitis treatment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Conjunctivitis Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on conjunctivitis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for conjunctivitis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The conjunctivitis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Drug Class: Antibiotics; Antiviral; Anti-Allergic; Artificial Tears
  • 2) By Disease Type: Allergic Conjunctivitis; Bacterial Conjunctivitis; Viral Conjunctivitis
  • 3) By Route Of Administration: Oral; Topical
  • 4) By End-Users: Hospitals; Homecare; Specialty Clinics; Other End-Users
  • Companies Mentioned: Pfizer Inc.; Johnson and Johnson; AbbVie Inc.; Novartis AG; Sanofi SA
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Conjunctivitis Treatment Market Characteristics

3. Conjunctivitis Treatment Market Trends And Strategies

4. Conjunctivitis Treatment Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Conjunctivitis Treatment Market Size and Growth

  • 5.1. Global Conjunctivitis Treatment Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Conjunctivitis Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Conjunctivitis Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Conjunctivitis Treatment Market Segmentation

  • 6.1. Global Conjunctivitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Antibiotics
  • Antiviral
  • Anti-Allergic
  • Artificial Tears
  • 6.2. Global Conjunctivitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Allergic Conjunctivitis
  • Bacterial Conjunctivitis
  • Viral Conjunctivitis
  • 6.3. Global Conjunctivitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral
  • Topical
  • 6.4. Global Conjunctivitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Homecare
  • Specialty Clinics
  • Other End-Users

7. Conjunctivitis Treatment Market Regional And Country Analysis

  • 7.1. Global Conjunctivitis Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Conjunctivitis Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Conjunctivitis Treatment Market

  • 8.1. Asia-Pacific Conjunctivitis Treatment Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Conjunctivitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Conjunctivitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Conjunctivitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Conjunctivitis Treatment Market

  • 9.1. China Conjunctivitis Treatment Market Overview
  • 9.2. China Conjunctivitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Conjunctivitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Conjunctivitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Conjunctivitis Treatment Market

  • 10.1. India Conjunctivitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Conjunctivitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Conjunctivitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Conjunctivitis Treatment Market

  • 11.1. Japan Conjunctivitis Treatment Market Overview
  • 11.2. Japan Conjunctivitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Conjunctivitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Conjunctivitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Conjunctivitis Treatment Market

  • 12.1. Australia Conjunctivitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Conjunctivitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Conjunctivitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Conjunctivitis Treatment Market

  • 13.1. Indonesia Conjunctivitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Conjunctivitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Conjunctivitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Conjunctivitis Treatment Market

  • 14.1. South Korea Conjunctivitis Treatment Market Overview
  • 14.2. South Korea Conjunctivitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Conjunctivitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Conjunctivitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Conjunctivitis Treatment Market

  • 15.1. Western Europe Conjunctivitis Treatment Market Overview
  • 15.2. Western Europe Conjunctivitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Conjunctivitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Conjunctivitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Conjunctivitis Treatment Market

  • 16.1. UK Conjunctivitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Conjunctivitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Conjunctivitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Conjunctivitis Treatment Market

  • 17.1. Germany Conjunctivitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Conjunctivitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Conjunctivitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Conjunctivitis Treatment Market

  • 18.1. France Conjunctivitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Conjunctivitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Conjunctivitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Conjunctivitis Treatment Market

  • 19.1. Italy Conjunctivitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Conjunctivitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Conjunctivitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Conjunctivitis Treatment Market

  • 20.1. Spain Conjunctivitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Conjunctivitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Conjunctivitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Conjunctivitis Treatment Market

  • 21.1. Eastern Europe Conjunctivitis Treatment Market Overview
  • 21.2. Eastern Europe Conjunctivitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Conjunctivitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Conjunctivitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Conjunctivitis Treatment Market

  • 22.1. Russia Conjunctivitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Conjunctivitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Conjunctivitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Conjunctivitis Treatment Market

  • 23.1. North America Conjunctivitis Treatment Market Overview
  • 23.2. North America Conjunctivitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Conjunctivitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Conjunctivitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Conjunctivitis Treatment Market

  • 24.1. USA Conjunctivitis Treatment Market Overview
  • 24.2. USA Conjunctivitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Conjunctivitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Conjunctivitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Conjunctivitis Treatment Market

  • 25.1. Canada Conjunctivitis Treatment Market Overview
  • 25.2. Canada Conjunctivitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Conjunctivitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Conjunctivitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Conjunctivitis Treatment Market

  • 26.1. South America Conjunctivitis Treatment Market Overview
  • 26.2. South America Conjunctivitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Conjunctivitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Conjunctivitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Conjunctivitis Treatment Market

  • 27.1. Brazil Conjunctivitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Conjunctivitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Conjunctivitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Conjunctivitis Treatment Market

  • 28.1. Middle East Conjunctivitis Treatment Market Overview
  • 28.2. Middle East Conjunctivitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Conjunctivitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Conjunctivitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Conjunctivitis Treatment Market

  • 29.1. Africa Conjunctivitis Treatment Market Overview
  • 29.2. Africa Conjunctivitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Conjunctivitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Conjunctivitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Conjunctivitis Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Conjunctivitis Treatment Market Competitive Landscape
  • 30.2. Conjunctivitis Treatment Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson and Johnson
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. AbbVie Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Novartis AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Sanofi SA
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Conjunctivitis Treatment Market Other Major And Innovative Companies

  • 31.1. Boehringer Ingelheim
  • 31.2. Viatris Inc.
  • 31.3. Teva Pharmaceutical Industries Ltd.
  • 31.4. Alcon Laboratories Inc.
  • 31.5. Sun Pharmaceutical Industries Ltd.
  • 31.6. Aurobindo Pharma Limited
  • 31.7. Dr. Reddy's Laboratories Ltd.
  • 31.8. Cipla Inc.
  • 31.9. Bausch Health Companies Inc
  • 31.10. Santen Pharmaceuticals Co. Ltd
  • 31.11. Lupin Limited
  • 31.12. Allergan PLC
  • 31.13. Alembic Pharmaceuticals Ltd
  • 31.14. Akorn Inc.
  • 31.15. Micro Labs Ltd.

32. Global Conjunctivitis Treatment Market Competitive Benchmarking

33. Global Conjunctivitis Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Conjunctivitis Treatment Market

35. Conjunctivitis Treatment Market Future Outlook and Potential Analysis

  • 35.1 Conjunctivitis Treatment Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Conjunctivitis Treatment Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Conjunctivitis Treatment Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer